Al-Warhi, T., H. Almahli, R. M. Maklad, Z. M. Elsayed, M. A. El Hassab, O. J. Alotaibi, N. Aljaeed, R. R. Ayyad, H. A. Ghabour, W. M. Eldehna, et al.,
"1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights",
Molecules, vol. 28, no. 7: MDPI, pp. 3203, 2023.
Abstractn/a
Ibrahim, K. A., M. K. El-Ashrey, M. O. N. A. T. KASHEF, and O. M. N. E. Y. A. M. HELMY,
"Alanine racemase a promising Helicobacter pylori drug target inhibited by propanoic acid",
Microbes and Infection, vol. 25, no. 7: Elsevier Masson, pp. 105167, 2023.
Abstractn/a
Hemeda, L. R., M. A. El Hassab, M. O. H. A. M. E. D. A. ABDELGAWAD, E. F. Khaleel, M. M. Abdel-Aziz, F. A. Binjubair, S. T. Al-Rashood, W. M. Eldehna, and M. K. El-Ashrey,
"Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi-and extensively drug resistant Mycobacterium tuberculosis",
Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1: Taylor & Francis, pp. 2250575, 2023.
Abstractn/a
El-Hussieny, M., M. A. Abd-El-Maksoud, F. M. Soliman, M. A. Fouad, and M. K. El-Ashrey,
"Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and $\beta$-amyloid aggregation",
Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1: Taylor & Francis, pp. 2166040, 2023.
Abstractn/a
El-Hussieny, M., M. A. Abd-El-Maksoud, F. M. Soliman, M. A. Fouad, and M. K. El-Ashrey,
"Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and $\beta$-amyloid aggregation",
Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1: Taylor & Francis, pp. 2166040, 2023.
Abstractn/a
Ghamry, H. I., A. Belal, M. K. El-Ashrey, H. O. Tawfik, R. I. Alsantali, A. J. Obaidullah, A. A. El-Mansi, and D. A. Rahman,
"Evaluating the ability of some natural phenolic acids to target the main protease and AAK1 in SARS COV-2",
Scientific Reports, vol. 13, no. 1: Nature Publishing Group UK London, pp. 7357, 2023.
Abstractn/a
ElNaggar, M. H., A. A. Elgazar, G. Gamal, S. M. Hamed, Z. M. Elsayed, M. K. El-Ashrey, A. Abood, M. A. El Hassab, A. M. Soliman, R. A. El-domany, et al.,
"Identification of sulphonamide-tethered N-((triazol-4-yl) methyl) isatin derivatives as inhibitors of SARS-CoV-2 main protease",
Journal of enzyme inhibition and medicinal chemistry, vol. 38, no. 1: Taylor & Francis, pp. 2234665, 2023.
Abstractn/a
Mostafa, E. A., M. K. El-Ashrey, and S. T. Mahmoud,
"An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets",
BMC chemistry, vol. 17, no. 1: Springer International Publishing Cham, pp. 164, 2023.
Abstractn/a
Mohamed, A. R., A. Mostafa, M. A. El Hassab, G. M. Hedeab, S. H. Mahmoud, R. F. George, H. H. Georgey, N. A. M. Gawad, and M. K. El-Ashrey,
"Insights into targeting SARS-CoV-2: design, synthesis, in silico studies and antiviral evaluation of new dimethylxanthine derivatives",
RSC Medicinal Chemistry, vol. 14, no. 5: Royal Society of Chemistry, pp. 899–920, 2023.
Abstractn/a
Ghanem, A., M. A. Ali, M. A. Elkady, S. A. S. Mageed, M. A. El Hassab, M. K. El-Ashrey, O. A. Mohammed, and A. S. Doghish,
"Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression",
Pathology-Research and Practice, vol. 250: Urban & Fischer, pp. 154807, 2023.
Abstractn/a
Elebeedy, D., A. Ghanem, S. H. Aly, M. A. Ali, A. H. I. Faraag, M. K. El-Ashrey, A. M. salem, M. E. A. Hassab, and A. A. E. I. Maksoud,
"Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights",
BMC microbiology, vol. 23, no. 1: BioMed Central London, pp. 173, 2023.
Abstractn/a